CytoDyn (CYDY) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Powered by 
Analysis
CytoDyn (CYDY) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -176.09% |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 93.04% |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -53.46% |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 99.48% |
| 10 | CytoDyn | 259.28 Mn | 259.28 Mn | - | -91.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -91.53% |
| Feb 28, 2026 | -193.12% |
| Nov 30, 2025 | -954.73% |
| Aug 31, 2025 | -137.98% |
| May 31, 2025 | 8.28% |
| Feb 28, 2025 | -18.07% |
| Nov 30, 2024 | -9.38% |
| Aug 31, 2024 | 599.85% |
| May 31, 2024 | -2,173.12% |
| Feb 29, 2024 | -639.90% |
| Nov 30, 2023 | 58.01% |
| Aug 31, 2023 | -347.46% |
| May 31, 2023 | 98.37% |
| Feb 28, 2023 | 54.76% |
| Nov 30, 2022 | -305.07% |
| Aug 31, 2022 | 5.68% |
| May 31, 2022 | -2,961.31% |
| Feb 28, 2022 | 80.44% |
| Nov 30, 2021 | 5.61% |
| Aug 31, 2021 | 81.20% |